Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$2.3 - $3.27 $493,453 - $701,562
-214,545 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.49 - $4.54 $171,028 - $311,834
68,686 Added 47.09%
214,545 $556,000
Q3 2018

Nov 14, 2018

SELL
$3.4 - $4.84 $468,452 - $666,855
-137,780 Reduced 48.58%
145,859 $696,000
Q2 2018

Aug 14, 2018

BUY
$3.03 - $4.98 $859,426 - $1.41 Million
283,639 New
283,639 $1.17 Million

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $140M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.